168 related articles for article (PubMed ID: 9542584)
21. Mini- and full-length dystrophin gene transfer induces the recovery of nitric oxide synthase at the sarcolemma of mdx4cv skeletal muscle fibers.
Decrouy A; Renaud JM; Lunde JA; Dickson G; Jasmin BJ
Gene Ther; 1998 Jan; 5(1):59-64. PubMed ID: 9536265
[TBL] [Abstract][Full Text] [Related]
22. Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha 7B expression and caveolin-3 distribution.
Côté PD; Moukhles H; Carbonetto S
J Biol Chem; 2002 Feb; 277(7):4672-9. PubMed ID: 11741881
[TBL] [Abstract][Full Text] [Related]
23. Species-independent expression of nitric oxide synthase in the sarcolemma region of visceral and somatic striated muscle fibers.
Grozdanovic Z; Nakos G; Dahrmann G; Mayer B; Gossrau R
Cell Tissue Res; 1995 Sep; 281(3):493-9. PubMed ID: 7553769
[TBL] [Abstract][Full Text] [Related]
24. Fibre-related nitric oxide synthase (NOS) in Duchenne muscular dystrophy.
Punkt K; Schering S; Fritzsche M; Asmussen G; Minin EA; Samoilova VE; Müller FU; Schmitz W; Hasselblatt M; Paulus W; Müller-Werdan U; Slezak J; Koehler G; Boecker W; Buchwalow IB
Acta Histochem; 2007; 109(3):228-36. PubMed ID: 17313973
[TBL] [Abstract][Full Text] [Related]
25. Absence of nitric oxide synthase I despite the presence of the dystrophin complex in human striated muscle.
Grozdanovic Z; Christova T; Gosztonyi G; Mellerowicz H; Blottner D; Gossrau R
Histochem J; 1997 Feb; 29(2):97-104. PubMed ID: 9147066
[TBL] [Abstract][Full Text] [Related]
26. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha-syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase.
Thomas GD; Shaul PW; Yuhanna IS; Froehner SC; Adams ME
Circ Res; 2003 Mar; 92(5):554-60. PubMed ID: 12600881
[TBL] [Abstract][Full Text] [Related]
27. Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters.
Segal SS; Brett SE; Sessa WC
Am J Physiol; 1999 Sep; 277(3):H1167-77. PubMed ID: 10484439
[TBL] [Abstract][Full Text] [Related]
28. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
[TBL] [Abstract][Full Text] [Related]
29. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity.
Ohsawa Y; Toko H; Katsura M; Morimoto K; Yamada H; Ichikawa Y; Murakami T; Ohkuma S; Komuro I; Sunada Y
Hum Mol Genet; 2004 Jan; 13(2):151-7. PubMed ID: 14645200
[TBL] [Abstract][Full Text] [Related]
31. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
Wang S; Shen D
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.
Brenman JE; Chao DS; Xia H; Aldape K; Bredt DS
Cell; 1995 Sep; 82(5):743-52. PubMed ID: 7545544
[TBL] [Abstract][Full Text] [Related]
33. Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins.
Shiao T; Fond A; Deng B; Wehling-Henricks M; Adams ME; Froehner SC; Tidball JG
Hum Mol Genet; 2004 Sep; 13(17):1873-84. PubMed ID: 15238508
[TBL] [Abstract][Full Text] [Related]
34. New aspects of the location of neuronal nitric oxide synthase in the skeletal muscle: a light and electron microscopic study.
Rothe F; Langnaese K; Wolf G
Nitric Oxide; 2005 Aug; 13(1):21-35. PubMed ID: 15890548
[TBL] [Abstract][Full Text] [Related]
35. The nitric oxide synthase-1 and nitric oxide synthase-3/nitric oxide signalling systems in the heart of wild type mice and mouse mutants.
Planitzer G; Richter H; Gossrau R
Histochem J; 2002; 34(6-7):345-55. PubMed ID: 12769267
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide synthase (NOS) in mouse skeletal muscle development and differentiated myoblasts.
Blottner D; Lück G
Cell Tissue Res; 1998 May; 292(2):293-302. PubMed ID: 9560472
[TBL] [Abstract][Full Text] [Related]
37. Caveolin-3 is associated with the T-tubules of mature skeletal muscle fibers.
Ralston E; Ploug T
Exp Cell Res; 1999 Feb; 246(2):510-5. PubMed ID: 9925767
[TBL] [Abstract][Full Text] [Related]
38. Increased caveolin-3 levels in mdx mouse muscles.
Vaghy PL; Fang J; Wu W; Vaghy LP
FEBS Lett; 1998 Jul; 431(1):125-7. PubMed ID: 9684879
[TBL] [Abstract][Full Text] [Related]
39. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy.
Repetto S; Bado M; Broda P; Lucania G; Masetti E; Sotgia F; Carbone I; Pavan A; Bonilla E; Cordone G; Lisanti MP; Minetti C
Biochem Biophys Res Commun; 1999 Aug; 261(3):547-50. PubMed ID: 10441463
[TBL] [Abstract][Full Text] [Related]
40. NO is not substantially involved in afferent signalling in rat muscle spindles.
Gossrau R; Grozdanovic Z
Acta Histochem; 1997 Nov; 99(4):445-58. PubMed ID: 9429603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
